Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin After Prior Immuno-Oncology or Antibody-Drug Conjugate Therapy.
Ravi K GoyalJingchuan ZhangKeith L DavisMartina Sluga-O'CallaghanPeter A KaufmanPublished in: Breast cancer (Dove Medical Press) (2023)
These real-world data provide evidence for the clinical effectiveness outcomes of eribulin treatment among MBC patients previously treated with an IO or ADC.
Keyphrases
- metastatic breast cancer
- newly diagnosed
- end stage renal disease
- systematic review
- randomized controlled trial
- chronic kidney disease
- palliative care
- clinical trial
- peritoneal dialysis
- machine learning
- drug delivery
- adipose tissue
- combination therapy
- phase ii
- skeletal muscle
- study protocol
- open label
- smoking cessation
- patient reported
- data analysis
- chemotherapy induced